Côte d'Ivoire vs Lesotho: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Côte d'Ivoire
- Lesotho
How they compare
Côte d'Ivoire currently reports 22,691 deaths against 16,464 deaths in Lesotho, a difference of 6,227 deaths.
That makes Côte d'Ivoire's figure about 1.4 times Lesotho's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Lesotho ahead.
Côte d'Ivoire ranks 14th and Lesotho ranks 15th of 157 countries.
Côte d'Ivoire has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 5,020 deaths | 3,511 deaths | 1,509 deaths | Côte d'Ivoire |
| 2010s | 19,082 deaths | 15,323 deaths | 3,759 deaths | Côte d'Ivoire |
| 2020s | 22,683 deaths | 17,301 deaths | 5,382 deaths | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Côte d'Ivoire or Lesotho?
- Côte d'Ivoire, at 22,691 deaths against 16,464 deaths in Lesotho as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Côte d'Ivoire and Lesotho?
- 6,227 deaths, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Lesotho?
- 35 years are reported by both, from 1990 to 2024.
- How do Côte d'Ivoire and Lesotho rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Côte d'Ivoire ranks 14th and Lesotho ranks 15th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.